Enhanced Liver Health : Semaglutide may improve markers of non-alcoholic fatty liver disease (NAFLD), a condition commonly linked to obesity and diabetes
Giuseppe identifies relationships between specific ingredients and desired outcomes, allowing scientists to refine formulations faster and with greater precision, reducing trial and error, he told NutraIngredients
Here's What To Know You may have heard of Ozempic, and other GLP-1 drugs
It works by mimicking a natural hormone called GLP-1 (glucagon-like peptide-1), which regulates appetite and promotes a feeling of fullness
Meanwhile, obesity or overweight, worse renal function, unfavorable lipid profile (such as higher low-density lipoprotein cholesterol and lower high-density lipoprotein cholesterol), hypertension, and smoking are also associated with a higher risk of DPN (28, 30, 32, 33, 35, 38)